01-11-2017 EGA: Commission sponsored study shows Supplementary Protection Certificate (SPC) Manufacturing Waiver will create Jobs, strengthen the pharmaceutical sector and reduce medicine
24-10-2017 APMGR: APMGR requests the resignation of the Minister of Health and the President of NHIH
25-09-2017 MoH: Announcement of round table, organized to inform Romanian Manufacturers and Marketing Authorization Holders about the steps to be taken to meet the requirements of European Directive 2011/62, also known as the "Falsified Medicines Directive".
08-06-2017 EMVO: Announcement regarding the training video about the Onboarding Partner Portal has now been released.
29-05-2017 MoH Press release: ARPIM (Romanian June 6th (Tuesday), 2:00 PM, MoH - Association of International Medicine Producers) asked for a public debate on the MoH draft Order related to the amendment of MoH 1345/2016 regarding daily reporting of inventories and commercial operations with medicinal products for human use in the National Catalog of the prices of the medicinal products authorized for marketing in Romania by wholesale distribution units of medicines, importers, authorized manufacturers and closed and open circuit pharmacies.
24-11-2016 90 per cent of pharmaceutical industry-led clinical trials now published, says new study issued by the Association of the British Pharmaceutical Industry (ABPI)
18-11-2016 EMA: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2016
27-10-2016 European Commission (EC) Question & Answer document for patients builds trust and understanding on biosimilar medicines across Europe
18-10-2016 EMA: Use of metformin to treat diabetes now expanded to patients with moderately reduced kidney function
17-10-2016 EMA: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2016
06-10-2016 Medicines for Europe: Generic medicines save European countries 100 billion euro per year
27-09-2016 IQWIG issues opinion on ticagrelor (Brilinta, AstraZeneca) for prevention after myocardial infarction
21-09-2016 EMA: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2016 (corrected)
02-09-2016 Roche to reunite with ABPI
21-07-2016 NMMDA informs interested parties regarding medicines manufactured within the American company, Pharmaceutics International Inc.
12-07-2016 EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-8 July 2016
22-06-2016 NMMDA informs Healthcare Professionals with regard to safety issues associated with treatment with Thalidomide Celgene (thalidomide)
06-06-2016 EMA: 2015 annual report, published
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you